New research from MHP Health and ComRes looks at what impacts COVID-19 has had on the public’s health data sharing concerns, and asks how the industry can maintain confidence in data usage
During my time at Illumina I had a realisation: restricted access to data, and an industry-wide aversion to collaboration, was delaying and in some instances preventing the discovery of tre
Following the recent publication of the Department of Health’s response document on data security issues, Adam Marsh and Hassan Chaudhury highlight and assess the points that could have an impa
GSK’s Arexvy has become the first vaccine for respiratory syncytial virus (RSV) to be approved in the EU, getting the nod from the European Commission for use in older adu
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas
